The Beauty Health Company
General ticker "SKIN" information:
- Sector: Consumer Staples
- Industry: Household & Personal Products
- Capitalization: $191.9M (TTM average)
The Beauty Health Company does not follow the US Stock Market performance with the rate: -7.5%.
Estimated limits based on current volatility of 4.0%: low 0.80$, high 0.87$
Factors to consider:
- Earnings expected soon, date: 2026-05-14 amc
- Total employees count: 769 (-12.7%) as of 2024
- North and South America accounted for 64.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Reputation and brand risks, Supply chain disruptions, Strategic risks and growth management, Geopolitical risks
- Current price 27.6% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.19$, 2.67$]
- 2026-12-31 to 2027-12-31 estimated range: [1.35$, 2.88$]
Financial Metrics affecting the SKIN estimates:
- Positive: with PPE of -7.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 20.19 > 12.96
- Positive: Inventory ratio change, % of -2.88 <= -0.75
- Positive: 5.46 < Industry operating cash flow per share per price (median), % of 5.93
- Positive: 3.02 < Industry operating profit margin (median), % of 4.45
- Positive: -4.45 < Investing cash flow per share per price, % of -2.78
Short-term SKIN quotes
Long-term SKIN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $397.99MM | $334.29MM | $300.80MM |
| Operating Expenses | $528.91MM | $402.07MM | $321.60MM |
| Operating Income | $-130.92MM | $-67.77MM | $-20.80MM |
| Non-Operating Income | $29.03MM | $38.22MM | $14.86MM |
| Interest Expense | $13.65MM | $10.41MM | $19.30MM |
| R&D Expense | $10.10MM | $6.30MM | $5.60MM |
| Income(Loss) | $-101.89MM | $-29.55MM | $-5.94MM |
| Taxes | $-1.77MM | $-0.45MM | $3.58MM |
| Profit(Loss)* | $-100.12MM | $-29.10MM | $-9.50MM |
| Stockholders Equity | $59.39MM | $51.80MM | $61.10MM |
| Inventory | $91.32MM | $69.11MM | $48.00MM |
| Assets | $929.11MM | $685.68MM | $499.80MM |
| Operating Cash Flow | $21.75MM | $16.13MM | $37.50MM |
| Capital expenditure | $13.05MM | $6.79MM | $0.30MM |
| Investing Cash Flow | $-31.51MM | $-6.79MM | $-5.16MM |
| Financing Cash Flow | $-37.45MM | $-158.34MM | $-174.90MM |
| Earnings Per Share** | $-0.76 | $-0.23 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.